SCHEMBL71508

SCHEMBL71508

COC(=O)c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.82
KDM4E B2RXH2 5/20 0.71
ALDH1A1 P00352 5/20 0.71
MEN1 O00255 3/20 0.71
KMT2A Q03164 3/20 0.71
MAPT P10636 2/20 0.71
RAB9A P51151 2/20 0.71
HCRTR1 O43613 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
FTO Q9C0B1 1/20 0.65
PARP1 P09874 1/20 0.62
HPGD P15428 3/20 0.61
HSD17B10 Q99714 2/20 0.61
GABRP O00591 1/20 0.61
GABRD O14764 1/20 0.61
PDE5A O76074 1/20 0.61
LMNA P02545 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
PKM P14618 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28063129 0.92 KIF11 (0.70) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL30522267 0.90 KIF11 (1.00) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL2483277 0.90 KIF11 (1.00) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL26119516 0.89 KIF11 (0.71) KIF11KDM4EALDH1A1MEN1KMT2A
Carbazole SCHEMBL29280510 0.85 KIF11 (0.73) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL30209160 0.84 KIF11 (0.60) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL22100411 0.84 KIF11 (0.60) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL30571577 0.83 KIF11 (0.86) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL14376207 0.83 KIF11 (0.86) KIF11KDM4EALDH1A1MEN1KMT2A
SCHEMBL4726935 0.83 KDM4E (1.00) KIF11KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113796380-A Application of clausena lansium alkaloid and salt thereof in preparation of products for inhibiting phytophthora and/or ring rot activity 江西农业大学 2021-12-17 CN claimed
WO-2020254672-A1 SPATIAL CHARACTERISATION OF TARGET STRUCTURES IN A SAMPLE THERYCELL GMBH (DE) 2020-12-24 WO claimed
US-12319661-B2 Polycyclic compound EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) 2025-06-03 US disclosed
US-20250032448-A1 COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES KOH, Hwee Ling (SG) 2025-01-30 US disclosed
CN-115745970-B Polycyclic compound, preparation method and membrane 江苏裕事达新材料科技有限责任公司 2024-12-13 CN disclosed
US-12144797-B2 Compound for use in the treatment and/or prevention of parasitic mediated diseases KOH, Hwee Ling (SG) 2024-11-19 US disclosed
US-20230310373-A1 METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C BOEHRINGER INGELHEIM INT (DE) 2023-10-05 US disclosed
CN-111285853-B Polycyclic compound 江苏裕事达新材料科技有限责任公司 2023-07-28 CN disclosed
CN-115745970-A Polycyclic compound, preparation method and film 江苏裕事达新材料科技有限责任公司 2023-03-07 CN disclosed
CN-113796380-B Application of clausena lansium alkaloid and salt thereof in preparation of products for inhibiting phytophthora and/or ring rot activity 江西农业大学 2022-06-10 CN disclosed
CN-113796380-B Application of clausena lansium alkaloid and salt thereof in preparation of products for inhibiting phytophthora and/or ring rot activity 江西农业大学 2022-06-10 CN disclosed
US-20100160323-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-06-24 US disclosed
WO-2009117676-A2 NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 WO disclosed
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 US disclosed
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo XINJIANG HUASHIDAN PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2009-09-10 US disclosed
US-6713473-B1 6-CARBAMATE-1,2,3,4-TETRAHYDROCARBAZOLE DERIVATIVES; AFFINITY FOR NEUROPEPTIDE Y RECEPTORS MEIJI SEIKA KAISHA, LTD. (JP) 2004-03-30 US disclosed
EP-1345898-A2 TERACYCLIC CARBAZOLE DERIVATES AND THEIR USE AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2002050034-A2 TETRACYCLIC CARBAZOLE DERIVATES AND THEIR USE AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed
EP-1184373-A1 TRICYCLIC COMPOUNDS MEIJI SEIKA KAISHA LTD. (JP) 2002-03-06 EP disclosed
WO-1990015061-A1 NOVEL ALKALOIDS THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 1990-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160323-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 KIF11 2975/4885KDM4E 434/4885ALDH1A1 969/4885
US-20230310373-A1 METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C CTSC, CTSG, CTSZ KIF11 4354/4885KDM4E 1413/4885ALDH1A1 1189/4885
US-12144797-B2 Compound for use in the treatment and/or prevention of parasitic mediated diseases ICMT, ALG3, PFN1 KIF11 2974/4885KDM4E 2090/4885ALDH1A1 583/4885
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 KIF11 3230/4885KDM4E 375/4885ALDH1A1 784/4885
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo TPH1, HTR1F, TPH2 KIF11 3011/4885KDM4E 2869/4885ALDH1A1 324/4885
US-12319661-B2 Polycyclic compound CUTA, CDH1, DSG1 KIF11 3291/4885KDM4E 1855/4885ALDH1A1 878/4885
US-20250032448-A1 COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES EPX, PKD2, MPO KIF11 2575/4885KDM4E 2625/4885ALDH1A1 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.